government patient assistance program (PAP) operated by Pfizer. The PAP will provide the estimated 7.9 million treatment courses of FDA-approved, NDA-labeled Paxlovid free of charge to all eligible uninsured, Medicare and Medicaid patients through 2024, and to eligible uninsured and underinsured ...
Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Explore RxPathways Details Clinical Trials We proudly partner with thousands of study sites and tens of thousands of trial ...
and we continue to be the leading product in the CDK class by a wide range, with an 84% of total patient share in first-line use. However, we saw increased enrollment this quarter in our patient assistance program, which provides Ibrance free of charge...